Journal
BIOMEDICAL CHROMATOGRAPHY
Volume 26, Issue 12, Pages 1519-1528Publisher
WILEY
DOI: 10.1002/bmc.2726
Keywords
antiepileptics; UPLC-MS; MS; therapeutic drug monitoring; human plasma
Categories
Funding
- Ministry of Education, Culture, Sports, Science and Technology of Japan [21590156]
- Grants-in-Aid for Scientific Research [21590156, 23390138] Funding Source: KAKEN
Ask authors/readers for more resources
The purpose of this study was to develop an ultra-performance liquid chromatography tandem mass spectrometry (UPLC-MS/MS) method of 22 antiepileptics for routine therapeutic monitoring. The antiepileptics used in the analyses were carbamazepine, carbamazepine-10,11-epoxide, clobazam, N-desmethylclobazam, clonazepam, diazepam, N-desmethyldiazepam, ethosuximide, felbamate, gabapentin, lamotrigine, levetiracetam, N-desmethylmesuximide, nitrazepam, phenobarbital, phenytoin, primidone, tiagabine, topiramate, valproic acid, vigabatrin and zonisamide. After protein precipitation of 50?mu L plasma with methanol, the supernatant was diluted with water or was evaporated to dryness and reconstituted with mobile phase in the case of benzodiazepines. Separation was achieved on an Acquity UPLC BEH C18 column with a gradient mobile phase of 10?mm ammonium acetate containing 0.1% formic acid and methanol at a flow rate of 0.4?mL/min. An Acquity TQD instrument in multiple reaction monitoring mode with ion mode switching was used for detection. All antiepileptics were detected and quantified within 10?min, with no endogenous interference. All the calibration curves showed good linearity in the therapeutic range (r2?
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available